NCT04302584View on ClinicalTrials.gov

Norepinephrine / Vasopressin Combination for Resuscitation in Septic Shock

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 5, 2019

Study Completion Date

January 6, 2019

Conditions
Septic ShockAcute Kidney Injury
Interventions
DRUG

norepinephrine / Vasopressin

• The drug infusion was prepared as 100 IU of AVP (Pressyn; Ferring Inc., Toronto, Ontario, Canada) in 250 ml D5W, infused at the rate of 4.5 ml/h for 0.03 IU/min and 15 mg of Norepinephrine (Arterenol; Sanofi-Aventis, Frankfurt, Germany) in 250 ml D5W infused at the rate of 10 ml/h for 10 mcg/min using infusion pump.

Trial Locations (1)

Unknown

Hanaa El Gendy, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04302584 - Norepinephrine / Vasopressin Combination for Resuscitation in Septic Shock | Biotech Hunter | Biotech Hunter